🇺🇸 FDA
Patent

US 9249225

Single chain variable fragment anti-CD133 antibodies and uses thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9249225 (Single chain variable fragment anti-CD133 antibodies and uses thereof) held by Regents of the University of Minnesota expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00